Recently, there is an increased incidence of immunocompromised patients in medical fields. Frequent use of antibiotics, oncostatics, immunosuppressants and indwelling catheters lead to the causation of deep fungal infection. Deep fungal infection is fatal hence the proper diagnosis, management and prevention are of utmost importance.
In the gynecologic department of our institution, we had 109 cases that showed recalcitrant exothermic reaction to antibiotics. CAND-TEC and FUNGI-TEC, which detect fungal antigen in the blood, were utilized. The treatment modality was determined in relation to the degree of severity of fungal infection based on the results obtained. The cut-off values used in this study for CAND-TEC and FUNGI-TEC were (4+) and 11.0 pg/ml, respectively. If the results were above the given values, they were categorized as serum positive indicative of an existing deep fungal infection.
Comparison was made between serum positive and serum negative groups with regards to age, malignancy or benign disease, catheter use, leukocyte count, and c-reactive protein (CRP) values. In the serum fungus antigen positive group, 8.7% of the cases had benign diseases compared to 32.5% in the serum fungus antigen negative group. The difference was statistically significant (P<0.05). In the serum fungus antigen positive group, leukopenia of --4500/mm3 (52.1%) was significantly higher than that (12.5%) of antigen negative group (P<0.05). Moreover, the rate of death within one month from serum positivity (39.1%) in the serum fungus antigen positive group was higher than that (15.0%) in the serum fungus antigen negative group (P<0.05). This was also statistically significant.
The investigation of existence of systemic fungal infection with the use of our institution's protocol was noted to increase the efficacy of therapy to 68.0% as compared to 35-50% effectivity of reported conventional therapy.[Adv Obstet Gynecol, 55 (2) 161-166, 2003 (H.15.5)]
View full abstract